WHO ICTRP trial
Effect of saffron on inflammatory and antioxidant factors in patients with fatty…
IRCT201705309472N13 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT201705309472N13 |
|---|---|
| Public title | Effect of saffron on inflammatory and antioxidant factors in patients with fatty liver disease |
| Scientific title | Effect of saffron powder on serum concentration of hs-CRP, TNF-a, MDA, TAC, adiponectin and leptin in patients with non-alcoholic fatty live disease |
| Primary sponsor | Deputy of Research of Iran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | non alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified |
| Interventions | Intervention 1: Saffron powder group: One day, one tablet will contain 100 mg of saffron for 3 months (12 weeks). Intervention 2: Placebo group: For a period of 3 months (12 weeks), one tablet will contain 100 mg dextrose malto.;Treatment… |
| Registration date | Jul 26, 2017 |
| Target size | 76 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: